Drug profile · INN
penpulimab
penpulimab is a programmed cell death protein 1 inhibitor.
NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 1
Drug details — penpulimab
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.70
Quick answer
penpulimab is a programmed cell death protein 1 inhibitor.
Key facts
INN penpulimab
Mechanism Programmed cell death protein 1 inhibitor
Target Programmed cell death protein 1
Mechanism of action
Programmed cell death protein 1 inhibitor
Primary target: Programmed cell death protein 1
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is penpulimab?
penpulimab is a programmed cell death protein 1 inhibitor.